The 800k-1M shares per month for the note being sold had

New Post Public Reply Private Reply Replies (0) Message Board
trding Bored Lawyer #1932
281
The 800k-1M shares per month for the note being sold had been working, but the biggest this last week is two sellers, paulson and the note. Looks like 2M shares have been sold over the last week, much more than the past, which is putting great pressure on the share price. I assume the big paulson selling is probably old shares from Paulson investors that just got new shares (they had not been selling below 50c much until this week).

I trade a lot of convertible notes as almost every otc stock has them. Normally they don't have this nice monthly restriction, they can convert whenever, which is how much stocks end up below 1c. It is always good to know the price they got the shares, because they will not sell below that price. And also good to know how many shares they have left to sell. The more knowledge here, the better you can purchase shares at the lowest price. Grabbing as close as possible to their cost before they run out of shares. I have not looked at it in depth lately, but I'm guessing your 45c could be correct depending on when they converted these shares they are selling. I copied the old conversion dates from the 10Q.

I think the sp could handle both convertible notes without paulson selling, 2M per month or 100k per day selling, but definitely not both. They need to either close the pca deal or get the cancer trial going asap.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 5

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 6

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 4

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
NORD Honors Innovators Shaping Rare Disease Treatment

Updated Category News Views 8

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 5

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 5

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 6

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 7

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
Continue Reading